Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Nu-Med Plus (NUMD) Income towards Parent Company (2016 - 2025)

Nu-Med Plus' Income towards Parent Company history spans 10 years, with the latest figure at -$112341.0 for Q4 2021.

  • On a quarterly basis, Income towards Parent Company rose 77.87% to -$112341.0 in Q4 2021 year-over-year; TTM through Dec 2021 was -$839445.0, a 58.59% increase, with the full-year FY2025 number at -$56182.0, up 17.8% from a year prior.
  • Income towards Parent Company hit -$112341.0 in Q4 2021 for Nu-Med Plus, up from -$118366.0 in the prior quarter.
  • Over the last five years, Income towards Parent Company for NUMD hit a ceiling of $3.9 million in Q4 2017 and a floor of -$912488.0 in Q2 2020.
  • Historically, Income towards Parent Company has averaged -$72961.4 across 5 years, with a median of -$186876.0 in 2018.
  • Biggest five-year swings in Income towards Parent Company: soared 315.48% in 2017 and later crashed 290.35% in 2018.
  • Tracing NUMD's Income towards Parent Company over 5 years: stood at $3.9 million in 2017, then plummeted by 108.99% to -$350509.0 in 2018, then surged by 40.12% to -$209881.0 in 2019, then crashed by 141.9% to -$507696.0 in 2020, then skyrocketed by 77.87% to -$112341.0 in 2021.
  • Business Quant data shows Income towards Parent Company for NUMD at -$112341.0 in Q4 2021, -$118366.0 in Q3 2021, and -$251990.0 in Q2 2021.